Objective: Refractory coeliac disease type II (RCDII) is a severe complication of coeliac disease (CD) characterised by aberrant intraepithelial lymphocytes (IELs) of unknown origin that display an atypical CD3-CD7+icCD3+phenotype. In approximately 40% of patients with RCDII these lymphocytes develop into an invasive lymphoma. In the current study we aimed to identify the physiological counterpart of these cells. Design: RCDII cell lines were compared with T-cell receptor positive (TCR+) IEL (T-IEL) lines by microarray analysis, real-time quantitative PCR and flow cytometry. This information was used to identify cells with an RCDII-associated phenotype in duodenal biopsies from nonrefractory individuals by multicolour flow cytometry. Results: RCDII lines were transcriptionally distinct from T-IEL lines and expressed higher levels of multiple natural killer (NK) cell receptors. In addition to the CD3-CD7+icCD3+phenotype, the RCDII lines were distinguishable from other lymphocyte subsets by the absence of CD56, CD127 and CD34. Cells matching this surface lineage-negative (Lin-) CD7+CD127-CD34-phenotype expressed a functional interleukin-15 (IL-15) receptor and constituted a significant proportion of IELs in duodenal specimens of patients without CD, particularly children, and were also found in the thymus. In patients without CD, the Lin-CD7+CD127-CD34-subset was one of four subsets within the CD3-CD7+icCD3+population that could be distinguished on the basis of differential expression of CD56 and/or CD127. Conclusion: Our studies indicate that the CD3-CD7+icCD3+population is heterogeneous and reveal the existence of a Lin-subset that is distinct from T, B, NK and lymphoid tissue inducer cells. We speculate that this IL-15 responsive population represents the physiological counterpart of aberrant cells expanded in RCDII and transformed in RCDII-associated lymphoma.

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
doi.org/10.1136/gutjnl-2012-302265, hdl.handle.net/1765/40812
Gut (English Edition): an international journal of gastroenterology & hepatology
Erasmus MC: University Medical Center Rotterdam

Schmitz, F., Tjon, J., Lai, Y., Thompson, A., Kooy-Winkelaar, Y., Lemmers, R., … Koning, F. (2013). Identification of a potential physiological precursor of aberrant cells in Refractory coeliac disease type II. Gut (English Edition): an international journal of gastroenterology & hepatology, 62(4), 509–519. doi:10.1136/gutjnl-2012-302265